1548 — Genscript Biotech Share News
0.000.00%
Last trade - 00:00- HK$76.05bn
- HK$72.43bn
- $959.53m
Genscript Biotech hits 6-week peak on forecasting H1 return to profit
Brief: Genscript Biotech Expects Profit Before Tax Of $175.4M-$204.6M In HY
GenScript Biotech jumps on associate's Carvykti sales beat
US lawmakers renew concerns about GenScript's ties to China
US lawmakers renew concerns about GenScript's ties to China
Brief: Genscript Biotech Says Unit Receives $213.8 Million Under R+A Agreement
Alphamab Oncology leads slide in HK pharma stocks on Trump's plan to trim medicine prices
GenScript jumps on associate's cancer drug's $334 mln sales
Brief: Genscript Biotech Says Liu Zhenyu Tendered Resignation As Rotating CEO
Brief: Genscript Biotech Says Probio Nanjing Agrees To Grant To Lanova An Exclusive License For Anti-Pd-1 Single Domain Antibodies
Legend Biotech gains as key shareholder to deconsolidate co
Genscript jumps on expected gains from Legend Biotech deconsolidation
Brief: Genscript Biotech Announces Deconsolidation Of Legend Biotech Corp And Its Subsidiaries
Brief: Legend Biotech Receives Approval From China National Medical Products Administration For Cell Therapy Product, Ciltacabtagene Autoleucel (Cilta-Cel)
Brief: Genscript Biotech Corp Posts H1 Gross Profit USD 307 Mln
Brief: Genscript Biotech Sees $505.2 Mln To $589.4 Mln In Revenue For HY
GenScript nears 7-year low after US lawmakers ask for briefing on co's China links
US lawmakers ask FBI for briefing on GenScript Biotech's links to China (updated)
US lawmakers ask FBI for briefing on GenScript Biotech's links to China